International Clinics
Daily
FDA approves atezolizumab with chemotherapy after surgery for stage III dMMR colon cancer
On 8 October 2026 the FDA approved Tecentriq (atezolizumab) with chemotherapy as adjuvant treatment for stage III colon cancer.